Back

Mavacamten versus septal ablation: prognostic differences in 1-year cardiovascular events for HOCM with resting LVOTG ≥50 mmHg

29 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Improving diagnosis and treatment in hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Bi Huang

The First Affiliated Hospital of Chongqing Medical University, Chongqing (China)

5 More presentations in this session

Presentation thumbnail
Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Clinical Outcomes in Patients with Hypertrophic Cardiomyopathy
Doctor S. Shin (Incheon, KR)
Abstract Slides Video
Presentation thumbnail
Baseline global longitudinal strain and mechanical dispersion predict ejection fraction decline during mavacamten therapy in obstructive hypertrophic cardiomyopathy
Doctor I. Cergan (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Impact of peak provoked left ventricular outflow tract gradients on health-related quality of life in patients with hypertrophic cardiomyopathy: a real-world cross-sectional survey
Doctor P. Gebrehiwet (South San Francisco, US)
Abstract Slides Video
Presentation thumbnail
Heterogeneous left atrial strain trajectories during mavacamten therapy in obstructive hypertrophic cardiomyopathy
Doctor D. Jensen (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
MRI-derived wall thickness heterogeneity in hypertrophic cardiomyopathy and in carriers of sarcomeric gene mutations
Doctor R. Licordari (Messina, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Improving diagnosis and treatment in hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
The cardiac myosin inhibitor mavacamten reduces even extreme left ventricular outflow gradient in obstructive hypertrophic cardiomyopathy already after one week of treatment
12 December 2024
thumbnail
Congress Session
Bipolar ablation
31 March 2025
thumbnail
Congress Presentation
Does age influence follow-up after alcohol septal ablation in hypertrophic obstructive cardiomyopathy?
28 August 2021
thumbnail
Congress Presentation
Earlier surgical myectomy vs. waiting for a Class I indication is associated with improved long-term survival in symptomatic hypertrophic obstructive cardiomyopathy patients
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources